Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows

v3.19.3
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows from Operating Activities:    
Net loss $ (15,888) $ (24,748)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,444 2,336
Issuance of common shares - Founders Agreement 198 815
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 632 661
Other receivables - related party 1,252 326
Accounts payable and accrued expenses (5,282) 2,410
Net cash used in operating activities (16,644) (18,200)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock 0 23,012
Offering costs for the issuance of common stock 0 (2,184)
Proceeds from issuance of common stock - At-the-market offering 7,904 7,981
Offering costs for the issuance of common stock - At-the-market offering (195) (234)
Net cash provided by financing activities 7,709 28,575
Net (decrease) increase in cash and cash equivalents (8,935) 10,375
Cash and cash equivalents at beginning of period 21,995 19,225
Cash and cash equivalents at end of period 13,060 29,600
Supplemental disclosure of noncash investing and financing activities:    
Issuance of common shares - Founders Agreement $ 1,748 $ 2,296